Comparative efficacy of spironolactone, eplerenone, nebivolol and moxonidine in patients with resistant arterial hypertension. UJC [Internet]. 2019 Jan. 8 [cited 2024 Nov. 24];25(6):65-71. Available from: https://ucardioj.com.ua/index.php/UJC/article/view/76